IMNN Imunon, Inc.
$0.88▼ -26.37%
Healthcare
Other
After hours
$0.89▲ +1.11%
Oct 27, 5:29 PM ET
Volume 537.0K
Avg Volume (10D) 65.4K
Key Metrics & Fundamentals
Market Cap
$4.92M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.83 - 4.90
% vs 50 MA
-35.44%
% vs 200 MA
-61.53%
RSI-14
30.8
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.57
Free Cash Flow
-$3.99M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$4.20M
COGS
–
Operating Exp
$4.31M
Operating Income
-$4.31M
EBIT
-$4.31M
Pretax Income
-$4.25M
Net Income
-$4.25M
EPS (Diluted)
-0.84
Price & Volume History
Loading chart…
Recent News

IMUNON Announces Strategic Sale of ThermoDox®
GlobeNewswire · Oct 21, 2026 8:15 AM ET

IMUNON to Participate in Upcoming Investor Conferences
GlobeNewswire · Oct 8, 2026 9:00 AM ET

IMNN: R&D Day Highlights IMNN-001 Data in Frontline Ovarian Cancer
Zacks Small Cap Research · Oct 1, 2026 11:40 AM ET

IMUNON Converts $1.2 Million of Debt-to-Equity
GlobeNewswire · Sep 29, 2026 8:00 AM ET

IMUNON Makes the Frontline Case for Phase 3 IMNN-001 Study: 14.7-Month OS Signal, Historical IL-12 Safety Barriers Overcome, Enrolling Ahead of Plan
GlobeNewswire · Sep 24, 2026 8:05 AM ET

IMUNON Reports Independent Data Monitoring Committee Recommends Continued Phase 2 Development of IMNN-001 Following Favorable Safety Review
GlobeNewswire · Sep 22, 2026 8:05 AM ET

IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001
GlobeNewswire · Sep 10, 2026 9:30 AM ET

IMUNON Announces Full Agenda and Speaker Lineup Ahead of 2026 R&D Day Highlighting IMNN-001 Clinical Progress
GlobeNewswire · Sep 9, 2026 8:30 AM ET

IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001
GlobeNewswire · Aug 26, 2026 8:30 AM ET
IMNN: Strong Enrollment Momentum Continuing for Phase 3 OVATION 3 Trial
Zacks Small Cap Research · Aug 19, 2026 8:10 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See IMNN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.